abrdn plc Trims Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

abrdn plc lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 227,184 shares of the medical equipment provider’s stock after selling 23,610 shares during the quarter. abrdn plc owned about 0.06% of Intuitive Surgical worth $118,658,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in ISRG. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical in the fourth quarter worth $26,000. Godsey & Gibb Inc. increased its holdings in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical in the third quarter worth $33,000. Decker Retirement Planning Inc. bought a new position in shares of Intuitive Surgical in the fourth quarter worth $36,000. Finally, Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical in the third quarter worth $38,000. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 28,843 shares of company stock worth $15,357,560 over the last three months. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG opened at $578.55 on Tuesday. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The company has a 50-day simple moving average of $550.40 and a two-hundred day simple moving average of $510.02. The firm has a market capitalization of $206.07 billion, a PE ratio of 90.26, a price-to-earnings-growth ratio of 5.51 and a beta of 1.39.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of research analyst reports. Piper Sandler reissued an “overweight” rating and issued a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. CICC Research initiated coverage on Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price on the stock. Raymond James increased their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Finally, Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.